Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:1653-1654
Published online before print February 28, 2008, doi: 10.1161/STROKEAHA.107.510552
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/6/1653    most recent
STROKEAHA.107.510552v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Truelsen, T.
Right arrow Articles by Bonita, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Truelsen, T.
Right arrow Articles by Bonita, R.
Related Collections
Right arrow Epidemiology
Right arrowRelated Article

(Stroke. 2008;39:1653.)
© 2008 American Heart Association, Inc.


Editorials

Epidemiological Transition of Stroke in China?

Thomas Truelsen, MD, PhD, DMSC Ruth Bonita, MPH, PhD

From the Department of Neurology (T.T.), Bispebjerg University Hospital, Copenhagen NV, Denmark; and the School of Population Health (R.B.), University of Auckland, Auckland, New Zealand.

Correspondence to Thomas Truelsen, MD, PhD, DMSC, Department of Neurology, Bispebjerg University Hospital, Bispebjerg Bakke 23, 2400 Copenhagen NV, Denmark. E-mail truelsen{at}post3.tele.dk


Key Words: epidemiology • incidence rate • stroke

See related article, pages 1668–1674.

Results from the long-term surveillance of stroke as part of the Sino-MONICA project in Beijing, published in this month’s issue of Stroke, show marked changes in both stroke incidence and stroke subtypes.1 The authors conclude that characteristics of the stroke transition found over 2 decades and which reflected a period of economic development is in line with the theory of the epidemiological transition.2 According to this theory, with economic and social development, the disease pattern in a population shifts from a predominance of nutritional deficiencies and infectious diseases to chronic, noncommunicable diseases such as cardiovascular disease, diabetes, and cancers. A first step in the transition is associated with an increasing disease burden related to hypertension such as hemorrhagic stroke, whereas ischemic heart disease and ischemic stroke emerge at later stages in the transition. China and other Asian countries appear to be in the midstage of the transition supported by studies reporting higher hemorrhagic stroke rates compared with white populations in high-income countries.3

The authors suggest that economic development has had an early impact on lifestyle in Beijing, whereas the level of treatment and control of risk factors may be delayed.1 In the Sino-MONICA population, the observed changes occurred during a period where total fat intake, cholesterol levels, and obesity increased and there was a modest improvement in the control of hypertension. In addition, in line with the fact that China is one of the largest producers and consumers of cigarettes, two-thirds of all Chinese men use tobacco.4 Diabetes prevalence has also increased in Chinese populations in recent decades.5 It is possible that the effects of today’s prevalence of risk factors in the Chinese population will reach many years into the future, not only with respect to stroke, but also ischemic heart disease.

Establishing a link between the epidemiological transition and economic level in the population is complex. Early in the transition, high income may increase the risk of hemorrhagic and ischemic stroke whereas at later stages, the poorer population is burdened.6,7 Thus, while economic development may, in general, be associated with the epidemiological transition, local health policy is equally important in determining the extent to which a population has to go through each of the steps, the duration of each step, and whether all subgroups within the population will be burdened. Early prevention through legislation and active public health policy could reduce the potential harmful effects of an improved economy. A recent analysis of the health effects of reducing salt intake and implementation of key elements of the World Health Organization Framework Convention on Tobacco Control at the population level would result in 4.5 million fewer deaths in China over 10 years.8 The majority of these averted deaths would be from fewer cardiovascular disease events, including stroke. The estimated financial costs associated with these two interventions were 0.2 USD per person in China.8

The latest results from the Sino-MONICA-Beijing project shed important light on the relatively rapid changes taking place in this major city; they also raise some questions. Throughout the data registration period, from 1984 to 2004, the team adhered to the clinical criteria for stroke events outlined by the World Health Organizations MONICA project.9 The diagnosis of stroke subtype depended on clinical symptoms and lumbar puncture in the early stage of the study in the absence of access to CT scans. The proportion of patients who had a CT examination increased dramatically—from 4% in 1984 to 90% by 1994 and 97% in 2004. This change in practice is likely to have affected the classification of stroke subtypes, at least for the earlier decade. Rates for first-ever hemorrhagic stroke remained stable around 40 to 50/100 000 in the early phase but was then followed by a rapid decrease from 40/100 000 in 2000 to only 26/100 000 in 2004; at the same time, this pattern coincided with a marked increase in ischemic stroke rates. The decrease in stroke case-fatality from one-in-four in 1995 to less than one-in-ten in 2004 is dramatic and is in line with the lower case fatality for ischemic stroke but needs confirmation.

The epidemiological transition is a useful, but blunt, tool for understanding trends and changes in disease burden in populations for the use of preventing increases in new diseases. It is to be regarded as an opportunity for health policy leaders to react timely.

The authors are to be congratulated on their comprehensive and sustained approach to studying stroke in Beijing. We hope that this work will continue as the social and economic context changes in China. However, action is even more important than further research. It is imperative that the evidence presented is converted into a high level and sustained government commitment to the prevention and control of all chronic, noncommunicable diseases and their risk factors.

Acknowledgments

Disclosures

None.

Footnotes

The opinions in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. Zhao D, Liu J, Wang W, Zeng Z, Chen J, Liu J, Sun J, Wu Z. Epidemiological transition of stroke in China: twenty-one year observational study from the Sino MONICA-Beijing project. Stroke. 2008; 39: 1668–1674.
  2. Omran AR. The epidemiologic transition: a theory of the epidemiology of population change. Milbank Mem Fund Q. 1971; 49: 509–538.[CrossRef][Medline] [Order article via Infotrieve]
  3. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke. 2003; 34: 2091–2096.[Abstract/Free Full Text]
  4. Gu D, Wu X, Reynolds K, Duan X, Xin X, Reynolds RF, Whelton PK, He J; InterASIA Collaborative Group. Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. Am J Public Health. 2004; 94: 1972–1976.[Abstract/Free Full Text]
  5. Xu L, Xie X, Wang S, Wang Y, Jonas JB. Prevalence of diabetes mellitus in China. Exp Clin Endocrinol Diabetes. 2008; 116: 69–70.[CrossRef][Medline] [Order article via Infotrieve]
  6. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation. 2001; 104: 2746–2753.[Abstract/Free Full Text]
  7. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease. Circulation. 1993; 88: 1973–1998.[Abstract/Free Full Text]
  8. Asaria P, Chisholm D, Mathers C, Ezzati M, Beaglehole R. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet. 2007; 370: 2044–2053.[CrossRef][Medline] [Order article via Infotrieve]
  9. Asplund K, Bonita R, Kuulasmaa K, Rajakangas AM, Schaedlich H, Suzuki K, Thorvaldsen P, Tuomilehto J. Multinational comparisons of stroke epidemiology. Evaluation of case ascertainment in the WHO MONICA Stroke Study. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease. Stroke. 1995; 26: 355–360.[Abstract/Free Full Text]

Related Article:

Epidemiological Transition of Stroke in China: Twenty-One–Year Observational Study From the Sino-MONICA-Beijing Project
Dong Zhao, Jing Liu, Wei Wang, Zhechun Zeng, Jun Cheng, Jun Liu, Jiayi Sun, and Zhaosu Wu
Stroke 2008 39: 1668-1674. [Abstract] [Full Text] [PDF]




This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/6/1653    most recent
STROKEAHA.107.510552v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Truelsen, T.
Right arrow Articles by Bonita, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Truelsen, T.
Right arrow Articles by Bonita, R.
Related Collections
Right arrow Epidemiology
Right arrowRelated Article